Relmada Therapeutics Inc
NASDAQ:RLMD
Relmada Therapeutics Inc
NASDAQ:RLMD
Price:
7.21
USD
0.56%
Market Closed
Market Cap:
$756.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
Altius Renewable Royalties Corp
OTC:ATRWF
|
CA |
|
Domtar Corp
TSX:UFS
|
US |
|
M
|
Morningstar Inc
XMUN:MRS
|
US |
|
Svenska Cellulosa SCA AB
F:SCA1
|
SE |
|
Svenska Cellulosa SCA AB
F:SCA0
|
SE |
|
Barclays PLC
LSE:BARC
|
UK |
|
Signet Jewelers Ltd
NYSE:SIG
|
BM |
|
Xtb SA
F:9PR
|
PL |
|
Abivax SA
PAR:ABVX
|
FR |
|
I
|
IAMGOLD Corp
NYSE:IAG
|
CA |
|
Persistent Systems Ltd
NSE:PERSISTENT
|
IN |
|
G
|
GM Leather SpA
MIL:GML
|
IT |
Wall St Price Targets
RLMD Price Targets Summary
Relmada Therapeutics Inc
Relmada Therapeutics Inc
Wall Street analysts forecast RLMD stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for RLMD is 14.03 USD with a low forecast of 10.1 USD and a high forecast of 19.95 USD.
Lowest Forecast
Price Target
10.1
USD
40% Upside
Average Forecast
Price Target
14.03
USD
95% Upside
Highest Forecast
Price Target
19.95
USD
177% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RLMD's stock price target?
Price Target
14.03
USD
14.03
USD
According to Wall Street analysts, the average 1-year price target for RLMD is 14.03 USD with a low forecast of 10.1 USD and a high forecast of 19.95 USD.
